ABL Diagnostics Société anonyme (EPA:ABLD)
France · Delayed Price · Currency is EUR 2.340
+0.140 (6.36%)
Aug 21, 2026, 5:26 PM CET
EPA:ABLD Revenue
In the year 2025, ABL Diagnostics Société anonyme had annual revenue of 6.95M EUR with 30.39% growth. ABL Diagnostics Société anonyme had revenue of 4.10M in the half year ending December 31, 2025, with 29.34% growth.
Revenue
6.95M
Revenue Growth
+30.39%
P/S Ratio
4.72
Revenue / Employee
362.08K
Employees
22
Market Cap
37.60M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.95M | 1.62M | 30.39% |
| Dec 31, 2024 | 5.33M | -282.46K | -5.03% |
| Dec 31, 2023 | 5.61M | -3.14M | -35.84% |
| Dec 31, 2022 | 8.75M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | 343.34K | -312.49K | -47.65% |
| Dec 31, 2017 | 655.83K | 105.70K | 19.21% |
| Dec 31, 2016 | 550.13K | 228.03K | 70.79% |
| Dec 31, 2015 | 322.10K | 287.17K | 822.05% |
| Dec 31, 2014 | 34.93K | 24.14K | 223.60% |
| Dec 31, 2013 | 10.80K | -1.87K | -14.73% |
| Dec 31, 2012 | 12.66K | -1.17K | -8.48% |
| Dec 31, 2011 | 13.83K | 928.00 | 7.19% |
| Dec 31, 2010 | 12.91K | 59.00 | 0.46% |
| Dec 31, 2009 | 12.85K | -2.90K | -18.43% |
| Dec 31, 2008 | 15.75K | 1.13K | 7.76% |
| Dec 31, 2007 | 14.61K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.92B |
| EssilorLuxottica Société anonyme | 29.29B |
| Ipsen | 4.29B |
| Sartorius Stedim Biotech | 3.01B |
| Novacyt | 22.96M |
| Klea Holding | 22.17M |
| Nicox | 16.77M |
| Fermentalg | 13.38M |